Joseph A Vita Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

10/2017	Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
2/2016	Endothelial Cell Bioenergetics and Mitochondrial DNA Damage Differ in Humans Having African or West Eurasian Maternal Ancestry.
6/2015	Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial.
4/2012	Effect of sulfasalazine on inflammation and endothelial function in patients with established coronary artery disease.
6/2010	Anthocyanins are bioavailable in humans following an acute dose of cranberry juice.
8/2009	The effect of L-arginine and creatine on vascular function and homocysteine metabolism.
4/2007	Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease.
4/2007	Effect of combined treatment with alpha-Lipoic acid and acetyl-L-carnitine on vascular function and blood pressure in patients with coronary artery disease.
2/2005	Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease.
11/2004	Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph A Vita Research Topics

Disease

20	Cardiovascular Diseases (Cardiovascular Disease) 05/2016 - 03/2003
15	Inflammation (Inflammations) 01/2020 - 04/2003
14	Coronary Artery Disease (Coronary Atherosclerosis) 10/2017 - 08/2002
11	Diabetes Mellitus 02/2016 - 05/2008
9	Hypertension (High Blood Pressure) 10/2017 - 08/2002
9	Hyperemia 12/2013 - 09/2003
9	Atherosclerosis 04/2012 - 04/2002
6	Obesity 02/2016 - 03/2003
3	Weight Loss (Weight Reduction) 01/2020 - 01/2005
3	Fistula 12/2016 - 01/2014
3	Insulin Resistance 01/2013 - 12/2007
3	Coronary Disease (Coronary Heart Disease) 05/2011 - 02/2004
3	Peripheral Arterial Disease 03/2010 - 05/2003
2	Vascular Diseases (Vascular Disease) 10/2017 - 02/2016
2	Heart Failure 05/2016 - 03/2006
2	Arteriovenous Fistula 01/2016 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2014 - 01/2013
2	Vascular Remodeling 04/2012 - 06/2010
2	Hypoxia (Hypoxemia) 02/2012 - 11/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2009 - 01/2008
2	Necrosis 06/2008 - 04/2002
2	Thrombosis (Thrombus) 01/2006 - 09/2003
1	Overweight 01/2020
1	Chronic Renal Insufficiency 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2014
1	Urinary Tract Infections (Urinary Tract Infection) 11/2013
1	Disease Progression 02/2010
1	Metabolic Diseases (Metabolic Disease) 02/2010
1	Apnea 11/2009

Drug/Important Bio-Agent (IBA)

10	Nitroglycerin (Dynamite)FDA LinkGeneric 10/2017 - 07/2003
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 04/2003
7	C-Reactive ProteinIBA 02/2016 - 07/2003
6	Biomarkers (Surrogate Marker)IBA 12/2015 - 10/2005
6	FlavonoidsIBA 12/2015 - 01/2005
6	Vasodilator Agents (Vasodilators)IBA 05/2008 - 09/2003
5	HDL CholesterolIBA 02/2016 - 03/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2005
4	PolyphenolsIBA 12/2015 - 01/2005
4	LipidsIBA 06/2015 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 04/2003
4	TeaIBA 08/2011 - 10/2003
3	AntioxidantsIBA 01/2020 - 07/2002
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 12/2007
3	Antihypertensive Agents (Antihypertensives)IBA 02/2016 - 02/2010
3	CholesterolIBA 06/2015 - 12/2007
3	Insulin (Novolin)FDA Link 12/2013 - 12/2007
3	Interleukin-6 (Interleukin 6)IBA 06/2008 - 12/2004
3	AldosteroneIBA 03/2006 - 10/2005
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2006 - 07/2004
2	EnzymesIBA 01/2020 - 08/2004
2	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 04/2007
2	Troponin IIBA 05/2016 - 04/2002
2	AdiponectinIBA 02/2016 - 02/2010
2	AdipokinesIBA 02/2016 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 05/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2014 - 07/2011
2	CytokinesIBA 02/2012 - 02/2010
2	Anthocyanins (Anthocyanin)IBA 05/2011 - 06/2010
2	oxidized low density lipoproteinIBA 09/2009 - 04/2003
2	HomocysteineIBA 08/2009 - 06/2007
2	Natriuretic PeptidesIBA 09/2007 - 06/2007
2	8-epi-prostaglandin F2alphaIBA 03/2006 - 03/2003
2	CreatinineIBA 02/2006 - 03/2003
2	ReninIBA 02/2006 - 10/2005
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2005 - 12/2004
1	Growth Differentiation Factor 15IBA 05/2016
1	LeptinIBA 02/2016
1	Mitochondrial DNA (mtDNA)IBA 02/2016
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 02/2016
1	Leptin ReceptorsIBA 02/2016
1	Fatty Acid-Binding ProteinsIBA 02/2016
1	NucleotidesIBA 02/2016
1	Protein Isoforms (Isoforms)IBA 09/2014
1	Vasoconstrictor AgentsIBA 02/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2014
1	ProstaglandinsIBA 02/2014
1	ErythritolIBA 01/2014
1	Sweetening Agents (Sweeteners)IBA 01/2014
1	Biological FactorsIBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2013
1	Serine (L-Serine)FDA Link 01/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	Protein Kinase CIBA 01/2013
1	5,21 - 12,17- dimetheneo- 18H- dibenzo(i,o)pyrrolo(3,4- 1)(1,8)diazacyclohexandecine- 18,10(19H)dione,8((dimethylamino)methyl)- 6,7,8,9,10,11- hexahydro,monomethanesulfonateIBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 04/2012
1	Endothelial Growth FactorsIBA 06/2010
1	Oxyhemoglobins (Oxyhemoglobin)IBA 11/2009
1	Arginine (L-Arginine)FDA Link 08/2009
1	CreatineIBA 08/2009
1	LigandsIBA 11/2008
1	CD40 Ligand (CD40L)IBA 11/2008
1	Tumor Biomarkers (Tumor Markers)IBA 06/2008

Therapy/Procedure

12	Therapeutics 01/2016 - 04/2002
3	Renal Dialysis (Hemodialysis) 12/2016 - 01/2014
2	Vascular Surgical Procedures 10/2007 - 05/2003
1	Polypharmacy 06/2015
1	Central Venous Catheters 01/2014